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Abstract
The Streptococcus pneumoniae pilus-1 is encoded by pilus islet 1 (PI-1), which has three clonal variants (clade I, II and III) and
is present in about 30% of clinical pneumococcal isolates. In vitro and in vivo assays have demonstrated that pilus-1 is
involved in attachment to epithelial cells and virulence, as well as protection in mouse models of infection. Several reports
suggest that pilus-1 expression is tightly regulated and involves the interplay of numerous genetic regulators, including the
PI-1 positive regulator RlrA. In this report we provide evidence that pilus expression, when analyzed at the single-cell level in
PI-1 positive strains, is biphasic. In fact, the strains present two phenotypically different sub-populations of bacteria, one
that expresses the pilus, while the other does not. The proportions of these two phenotypes are variable among the strains
tested and are not influenced by genotype, serotype, growth conditions, colony morphology or by the presence of
antibodies directed toward the pilus components. Two sub-populations, enriched in pilus expressing or not expressing
bacteria were obtained by means of colony selection and immuno-detection methods for five strains. PI-1 sequencing in the
two sub-populations revealed the absence of mutations, thus indicating that the biphasic expression observed is not due to
a genetic modification within PI-1. Microarray expression profile and western blot analyses on whole bacterial lysates
performed comparing the two enriched sub-populations, revealed that pilus expression is regulated at the transcriptional
level (on/off regulation), and that there are no other genes, in addition to those encoded by PI-1, concurrently regulated
across the strains tested. Finally, we provide evidence that the over-expression of the RrlA positive regulator is sufficient to
induce pilus expression in pilus-1 negative bacteria. Overall, the data presented here suggest that the observed biphasic
pilus expression phenotype could be an example of bistability in pneumococcus.
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Introduction
Streptococcus pneumoniae (S. pneumoniae) is a commensal pathogen
associated with severe diseases such as meningitis and bacteraemia
as well as pneumonia, sinusitis and otitis media [1–6]. In fact,
despite its pathogenic potential, the pneumococcus is a common
component of the human nasopharyngeal tract of children and
healthy adults [7]. This carriage state can persist for several
months and can be regarded as a risk factor for the development of
respiratory diseases, and also as the source for pneumococcal
transmission to other individuals [8–10]. Several pneumococcal
virulence factors have been identified, however, little is known
about the fundamental disease determinants and how they are
expressed during the development of disease [11–13]. S.
pneumoniae, like most streptococci, decorates its surface with long
multimeric filaments known as pili composed of covalently linked
subunits [14–17]. Although their biological function has not been
fully elucidated, pneumococcal pili have been associated with
virulence and the capability of the microorganism to better adhere
to epithelial cells and to colonize the nasopharynx [18,19]. In
addition, pilus-1 subunits have been shown to confer protection in
invasive mouse models of infection, and are therefore regarded as
potential candidates for a new generation of protein-based
vaccines targeting S. pneumoniae diseases [20,21]. The pneumococ-
cal pilus is encoded by the pilus islet 1 (PI-1), a 12 kb locus,
containing seven genes encoding a transcriptional regulator (RlrA),
which positively regulates pilus expression [22] and its own
expression, three pilus structural subunits (RrgA, RrgB and RrgC)
and three sortase enzymes (SrtC-1, SrtC-2 and SrtC-3), which
covalently assemble the pilus subunits on the bacterial surface [23–
26]. Several molecular epidemiological reports highlight that PI-1
is present in about 30% of the pneumococcal isolates, regardless of
the geographical origin and the disease outcome analyzed [17,27–
29]. PI-1 is clonally inherited by S. pneumoniae strains, and its
presence is associated with the genotype of the isolates rather than
the serotype. PI-1 exists in three variants, namely clade I, II and
III. Since each variant is associated with specific clones, PI-1
clades display different regional prevalence, strictly depending on
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21269the distribution of the clones [17,28]. Most of the PI-1 variability is
concentrated in the genes coding for the pilus components: RrgB,
the main pilus subunit, and RrgA, which is the major adhesin.
Given the potentially serious implications that the pilus might
have for disease and transmission, several reports have focused on
the evaluation of genetic regulators that are able to modulate pilus
expression and therefore bacterial virulence. Seven proteins, in
addition to the PI-1 positive regulator RlrA, were demonstrated by
different groups to negatively influence in vitro pilus expression levels
(MgrA, HK343, MerR, CbpS, TCS08, mntE, PsaR) [30–33].
However, it is still not clear whether all PI-1 positive pneumococci
express pili (in vitro and in vivo), and if genetic differences and growth
conditions can influence pilus-1 expression levels. In this work, we
analyze pilus-1 expression in a panel of 139 S. pneumoniae clinical
strains,andprovideevidencethatallofthestrainstested,regardlessof
serotype, genotype and growth conditions, present two phenotypi-
cally distinct sub-populations, expressing the pilus at high (here
defined as Pil+) and undetectable levels (here defined as Pil-). In
addition, the proportion of Pil+/Pil- was not influenced by the
presence of anti-RrgB antibodies during the growth. To better
elucidate the pilus expression phenotype, for a number of strains we
separated to about 95% purity two bacterial sub-populations,
enriched either in pilus expressing or pilus non-expressing pneumo-
cocci. PI-1 sequence analysis of the two sub-populations reveals the
absence of genetic phase variation events within the islet. Finally, we
compare the expression profiles of the two sub-populations in a panel
of S. pneumoniaeclinical strains and conclude that: 1) pilus expression is
regulated at the transcriptional level, 2) this regulation involves all PI-
1 components, and 3) there are no other genes in addition to those
encoded by PI-1 concurrently regulated across the isolates tested.
Results
Pilus-1 has a biphasic expression pattern
In order to elucidate pilus expression in S. pneumoniae, TIGR4
bacteria were grown, stained with antibodies raised against the
pilus components (RrgA, RrgB, and RrgC) and three surface
exposed proteins (PspC, PhtA and BgaA), and then analyzed by
flow cytometry (Fig. 1A) [34–37]. While the bacteria were found to
uniformly express PspC, PhtA and BgaA, the specific antibodies
for RrgA and RrgB revealed the presence of two sub-populations,
one expressing high levels of the pilus subunits (Pil+), while the
other displayed a mean fluorescence intensity (MFI) comparable to
the negative control (sera raised against an unrelated protein) (Pil-).
Interestingly, the analysis of bacteria labeled with anti-RrgC
antibodies revealed a single homogeneous population with an MFI
similar to the negative control, confirming that, in intact bacteria,
RrgC is not exposed on the bacterial surface [15]. To support the
data obtained by flow cytometry, the bacteria were incubated with
the antisera and then analyzed by immunofluorescence. As shown
in Figure 1B (and in the enlargement of Fig. 1C), bacteria were
uniformly stained by anti-capsular antibodies, whereas the RrgB
pilus specific signal was present only in a subset of bacteria (Pil+)
and undetectable in the others (Pil2).
S. pneumoniae pilus expression is not correlated with
genotype, clade type and serotype
Given the biphasic expression pattern observed in the TIGR4
strain,a collectionof139strainswasselectedoutof436 S.pneumoniae
PI-1 positive strains (see materials and methods) and analyzed for
pilus-1 expression by FACS analysis. All of the selected strains
revealed a biphasic pilus expression, with the proportion of Pil+
bacteria ranging from 5 to 95%. As presented in figure 2 for a
selection of strains, there was no correlation between the ratio of
Pil+ versus Pil- bacteria (pilus expression ratio) and the genotype,
clade type and serotype. In addition, there was no association with
the disease outcome of the isolates, as the pilus expression ratio was
heterogeneous in invasive, carriage and otitis media strains from the
same or different geographical origins (data not shown).
A detailed analysis of the PI-1 sequence revealed the presence
of variableshort nucleotide repeats in the intergenic regions upstream
RrgA (2-6 CTATA repeats) and RrgB (poly-A tract containing 5 or 6
adenosine nucleotides). Since in other organisms the presence of
different repeat numbers in the promoter region accounts for variable
expression of the downstream gene [38–40], we hypothesized that
these sequence repeats could act as regulation signals for RrgA and
Figure 1. Pilus components display a biphasic expression pattern. A) TIGR4 bacteria were labeled with anti-RrgA, RrgB clade I, RrgC, BgaA
(beta-galactosidase), PhtA (pneumococcal histidine triad protein A) or PspC (pneumococcal surface protein C, also known as CbpA,) primary
antibodies (1:400 dilution), and with FITC anti-mouse IgG secondary antibodies (1:100 dilution). Bacterial staining was analyzed by flow cytometry
(FACS-Calibur). Sera of mice immunized with PBS were used as negative control. B,C) TIGR4 bacteria were processed for immunofluorescence, stained
with mouse anti-RrgB antibodies (1:2000 dilution) (red) and with S. pneumoniae anti-capsular antibodies (Omniserum 1:2000 dilution) (green).
Imaging was performed with a confocal microscope. Scale bar is 4 mm in panel B and 1 mm in panel C.
doi:10.1371/journal.pone.0021269.g001
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the number of repeats and the pilus expression ratio in the 44 strains
analyzed [41] (data not shown).
Pilus expression ratio remains unchanged growing the
bacteria under different conditions or in the presence of
RrgB antisera
The identification of factors able to modulate pilus-1 expression
in vitro, and, in particular, to enhance the pilus expression ratio
could facilitate the understanding of the pilus role in vivo.
Therefore, three S. pneumoniae strains (TIGR4, 6B Finland 12
and 35B SME 15) were grown under several growth conditions
(for details see materials and methods) and pilus-1 expression
evaluated by flow cytometry, revealing that pilus-1 expression
remained unchanged (Fig. S1). Only the addition of 5-10% fresh
sheep blood to CDM medium slightly increased the pilus-1
expression ratio to variable extents in TIGR4, but the increase was
not reproducible in the other two strains (data not shown). Since
the pilus components are potential protein-based vaccine candi-
Figure 2. Pilus expression ratio is not correlated with serotype, genotype or clade type. Bacteria containing either PI-1 clade I (A), clade II
(B) or clade III (C), were labeled with clade specific anti-RrgB antibodies (1:400 dilution) and FITC anti-mouse IgG secondary antibodies (1:100 dilution).
Pilus-1 expression was then analyzed by flow cytometry (FACS-Calibur).
doi:10.1371/journal.pone.0021269.g002
Pneumococcal Pilus-1 Biphasic Expression
PLoS ONE | www.plosone.org 3 June 2011 | Volume 6 | Issue 6 | e21269dates, it is crucial to understand if the pilus expression ratio is
influenced by the presence of antibodies directed toward pilus
components. The three S. pneumoniae strains were therefore grown
in the presence of antibodies directed against RrgB (sera raised
against BgaA were used as negative control), and were allowed to
replicate seven cycles. The expression of pilus-1 was then verified
by FACS analysis revealing that the pilus expression ratio was
unaffected by the presence of the RrgB antisera (data not shown).
Two S. pneumoniae sub-populations enriched in Pil+ or
Pil- bacteria can be separated by colony selection
In order to verifyifPil+and Pil- bacteria after duplication maintain
their original pilus expression phenotype, bacteria, following a
sonication step, were grown on a plate as single colonies and then
analyzed for pilus expression. As shown in figure 3A, when colony
blot was performed with anti-RrgB antibodies, the colonies displayed
different RrgB intensities, but none were RrgB negative.
Colonies showing differential RrgB staining were selected and re-
grown. Analysis performed by flow cytometry revealed that the
majority of the colonies gave rise to populations with a ratio of pilus
expression similar to the original strain. However, some colonies
gave rise to either mostly Pil+ or Pil- sub-populations, defined as H
(high pilus expression) or L (low pilus expression) sub-populations
(Fig. 3B). Despite numerous attempts, completely positive or
negative sub-populations were never obtained, as there were always
Pil+ and Pil- in the L and H sub-populations, respectively (Fig. 3C
Figure 3. Stable separation of enriched high (H) and low (L) pilus-1 expressing sub-populations. A) TIGR4 pilus-1 expression was
revealed on single colonies by colony immunoblot using anti-RrgB clade I antibodies (green, black and red circles correspond to colonies displaying
low, medium or high RrgB specific signal intensities, respectively). Bacteria recovered from the growth of different colonies were stained with anti-
RrgB clade I antibodies and analyzed by flow cytometry (B). The bacteria expressing (Pil+) and non- expressing (Pil-) the pilus-1 are indicated in the L
(green) and H (red) enriched sub-populations, and in the wt (black). H and L sub-populations were stained for immunofluorescence (C and D).
Bacteria were incubated with mouse anti-RrgB antibodies (1:2000 dilution) (red) and with S.pneumoniae anti-capsular antibodies (Omniserum 1:2000
dilution) (green). Imaging was performed with a confocal microscope. Scale bar is 5 mm.
doi:10.1371/journal.pone.0021269.g003
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stably maintained after consecutive re-growths and long-term
storage at -80uC.
In addition, since in S. pneumoniae phase variability is commonly
associated with the widely known colony morphology phenotype
variation (opaque/transparent) [42–45], we sought to determine if
different colony opacity was related to a specific pilus expression ratio.
Bacteria grown on a plate as single colonies, following the
identification of different morphology (opaque or transparent), were
processed by immuno-blot analysis with anti RrgB antibodies.
Interestingly, the different RrgB intensities observed (corresponding
to different pilus expression ratios) were completely unrelated to the
colony morphology.
PI-1 components expression is undetectable in pilus-1
negative bacteria
The S. pneumoniae pilus-1 polymerization is a complex and tightly
coordinated process, not yet fully elucidated, requiring the
simultaneous involvement of pilus components and bacterial
sortases [23,46,47]. Following this observation, and in order to
gain more insight into the pilus polymerization mechanism, the
expression levels of the single PI-1 components were evaluated in
Pil- bacteria. In this regard, whole bacterial lysates of the TIGR4H
and TIGR4L sub-populations, along with a TIGR4L sub-
population further depleted of pilus positive bacteria (TIGR4
D)(see materials and methods) were probed with antibodies raised
against RrgA, B and C and SrtC1, 2 and 3 and SrtA (used as
experimental control). As reported in figure 4, the impossibility to
detect RrgA and RrgB on the surface correlates with the lack of
expression of all PI-1 components, both pilus-1 subunits and PI-1
sortases (as demonstrated by the absence of both the typical pilus
HMW ladder and protein monomers in TIGR4D).
Biphasic pilus expression is not due to phase variation
within the PI-1
Population heterogeneity of protein expression can result from
either genetic rearrangement, as is the case in phase variation, or
DNA modification, such as methylation, or it can be due to
epigenetic phenotypic variation (not caused by a change in DNA
sequence). In particular, phase variation is governed by random
frameshift mutations or site-specific recombination events, occur-
ring in open reading frames or promoter regions, and resulting in a
variable expression of a specific protein [48,49]. To exclude that
the biphasic pilus expression pattern was due to phase variation
events at the level of the positive regulator (rlrA), or, more in
general, to point mutations within PI-1, the islet was sequenced for
Figure 4. PI-1 encoded proteins are not expressed in RrgB negative bacteria. WB analysis performed on whole bacterial lysates of TIGR4 H
(H), L (L) or TIGR4 L depleted of RrgB positive bacteria (D), using polyclonal mouse antisera against RrgA, RrgB, RrgC (see High molecular weight
ladders), SrtC-1, SrtC-2 ,SrtC-3 (see bands indicated by arrows) and SrtA (used as loading control).
doi:10.1371/journal.pone.0021269.g004
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sub-populations (L and H) and in the wild-type. Neither alterations
in the genomic sequence nor uncertainties in the chromatograms
were observed, indicating that intra-islet gene mutations or
recombination events within PI-1 are not responsible for the
pilus-1 expression pattern.
Only PI-1 components are differentially regulated
between the H and L pilus expressing sub-populations
To evaluate if pilus-1 expression was regulated at the
transcriptional or translational level, total RNAs were extracted
from the H and L sub-populations of five strains, TIGR4, 19F
Taiwan 14, OREP4 (Clade I), 6BFin12 (Clade II) and 35B SME
15 (Clade III) (Fig. 5A). The expression profiles of the L versus the
H pilus expressing sub-populations were directly compared by
microarray analysis (see materials and methods). As shown in
figure 5C, the analysis of the log2 H/L signal intensity ratio curves
for PI-1 components in the five strains revealed that all the PI-1
genes (including rlrA) were differentially regulated in all the strains
tested. The different log2 signal intensity ratios observed among
the isolates clearly depends on the ability to enrich in Pil+ and Pil-
the H and L sub-populations, respectively. In fact, the strains 6B
Finland 12 and 35B SME 15 showing the lowest log2 H/L signal
intensity ratio, were the isolates with the least enriched sub-
populations (Fig. 5A). In addition, the log2 ratio expression levels
measured for the three sortases were consistently lower with
respect to the pilus components and the rlrA regulator (Fig. 5C).
This result is dependent on the different absolute expression levels
measured for the PI-1 genes both within the H and the L pilus
expressing sub-populations (sortase absolute expression levels were
about four-five times lower than pilus components) as reported in
figure 5D for the TIGR4 strain. This observation suggests the
Figure 5. Pilus-1 expression is regulated at the transcriptional level. A) High and low pilus expressing sub-populations of strains TIGR4
(Clade I), 19F Taiwan 14 (Clade I), OREP4 (Clade I), 6B Finland 14 (Clade II) and 35B SME 15 (Clade III) were labeled with clade specific anti-RrgB
antibodies (1:400 dilution) and FITC anti-mouse IgG secondary antibodies (1:100 dilution). Pilus-1 expression was then analyzed by flow cytometry
(FACS-Calibur). B) Schematic representation of PI-1. C) Log2 ratio values indicating the PI-1 genes differential expression in High vs. Low pilus
expressing sub-populations in the five above mentioned strains, as measured by spotted DNA microarray analysis. The data are measures of relative
gene expression during in vitro growth in liquid cultures. The values reported for each gene are the mean of all the spots and their replicates within
the array and of two independent experiments (bars represent standard deviations). D) Absolute gene expression levels of PI-1 genes measured for
TIGR4 high and low pilus expressing sub-populations by microarray hybridization. Absolute expression levels reported for each gene are the mean of
all the spots and their replicates within the array and of two independent experiments (bars represent the obtained standard deviations).
doi:10.1371/journal.pone.0021269.g005
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rrgB and srtC-1 as previously published [22]. In addition, the data
obtained further confirm the absence of a mRNA coding for the
protein annotated as hypothetical protein SP0465 [50]. The ratios
of H/L obtained for the PI-1 genes with the microarray
transcriptome analysis were further confirmed by qRT-PCR (see
materials and methods).
Interestingly, within the resolution limits of the microarray
analysis, no other conserved genes apart from PI-1 components
were identified as concurrently regulated in all the five strains tested
when we extended the expression profile analysis of the L versus H
pilus sub-populations to the complete genome (Fig. S2A, S2B).
Remarkably, changes in the expression rate of previously published
negative regulators [30–33] (expected to be up-regulated in the L
pilus expressing sub-population) remained undetected by our assay
(Fig. S2C).
Expression of the RlrA regulator in Pil- bacteria is
sufficient to induce pilus polymerization
In order to better evaluate the regulation of the pilus locus, the
effects on the pilus polymerization induced by the expression
within Pil- bacteria of RlrA (the positive regulator), RrgB or SrtC-
2 were evaluated. Briefly, the TIGR4 L sub-population was
transformed with a pMU1328 plasmid [51] containing the rrgB,
the srtC-2 or the rlrA gene (pMU1328 empty vector was used as
negative control). Following transformation, bacteria were studied
Figure 6. RlrA expression in pilus negative (Pil-) bacteria induces pilus polymerization. TIGR4 low pilus expressing bacteria transformed
with pMU1328 (panels A-C), pMU1328-Pc-rlrA (panels D-F), with pMU1328-Pc-rrgB (panels G-I) or with pMU1328-Pc-srtC-2 (panels J-L) were processed
for confocal microscopy immuno-fluorescence analysis by incubating S. pneumoniae with anti-capsular antibodies (Omniserum 1:2000 dilution)
(green, left panels) and mouse anti-RrgB antibodies (1:2000 dilution) (red, central panels). Right panels represent the merged signal of the left and
central panels. Scale bar is 4 mm.
doi:10.1371/journal.pone.0021269.g006
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(Fig. 6). The ratio of bacteria expressing the pilus was not altered
upon transformation with the pMU1328 empty plasmid (Fig. 6
panels A-C), while the expression of RlrA induced polymerization
of the pilus in 100% of the S. pneumoniae population (Fig. 6 panels
D-F). Interestingly, following the expression of RrgB or SrtC-2
(Fig. 6 panels G-I and J-L, respectively) the proportion of bacteria
able to polymerize the pilus on their surface did not change when
compared to the control. In detail, when RrgB was over-expressed,
RrgB was localized in clusters on the Pil- bacterial surface (Fig. 6
panels G-I), but remained un-polymerized (Fig. S3) due to the lack
of expression of the pilus specific sortases. On the other hand, the
expression of a functional SrtC-2 (Fig. 6 panels J-L and Fig. S3),
which in the presence of the RrgB monomer is sufficient to induce
RrgB polymerization (Fig. S3 and Text S1), did not induce in the
T4L sub-population any change in pilus components expression or
pilus polymerization. Taken together, these data indicate that the
expression of RlrA, unlike that of RrgB and SrtC-2, was sufficient
to induce the expression of all the other PI-1 components.
Discussion
Following their first identification in other gram-positive
bacteria, pili have been detected on the surface of the major
human pathogen S. pneumoniae and shown to be immunogenic and
involved in pathogenicity in in vivo and in vitro studies [18–20].
Epidemiological reports have defined that PI-1, coding for the
proteins implicated in pilus-1 biogenesis, is present in approxi-
mately 30% of the pneumococcal isolates and exists in three
genetically related variants [17,28,29].
The molecular structure of pilus-1 and the mechanism of pilus
assembly have been investigated, and a number of putative PI-1
genetic regulators have been described [15,26,30–33,52,53].
However, still very little is known about the regulation of pilus
expression, the environmental conditions able to modulate it and
the complex macromolecular machinery that regulates pili
biogenesis. In addition, in all the above mentioned studies, S.
pneumoniae pilus expression has always been evaluated not on a
single cell basis, but as an average behavior of a large population.
In this work, by using detection methods able to discriminate
single cells, we have compared the expression of the pilus to other
known surface exposed virulence factors in the laboratory
reference strain TIGR4. Unlike the other proteins tested, pilus-1
components were found to display a biphasic expression pattern.
The two phenotypically distinct sub-populations, Pil+ and Pil-, are
present in variable ratios in all the strains tested, similarly to what
has been previously observed for the transparent and opaque
variants in the intra-strain colony morphology phase variation
[44,45,54]. The pilus expression ratio is inherited by daughter cells
and is not influenced by bacterial genetic and epidemiological
characteristics, in vitro growth conditions, or growth in the presence
of pilus antisera. In addition, in contrast to what reported for the
opacity phenotype, where the opaque variant is the most frequent
phenotype found among invasive and acute otitis media isolates
and the transparent more associated to carriage [54,55], the pilus
expression ratios were similar in carriage and invasive isolates.
Furthermore, the majority of the colonies isolated on solid medium
from the same strain show a similar pilus expression pattern, thus
indicating that this may be influenced by some genetic traits of the
strain, still unidentified. However, some colonies generate bacterial
populations displaying different ratios of Pil+/Pil- bacteria. For
this reason, since the isolation of the clinical isolates from the
human host always implies a process of in vitro growth and
stochastic colony selection, the pilus expression ratios observed
may not be representative of the expression of pili in vivo. This
aspect needs further investigation.
Interestingly, despite numerous attempts using single colony
selection, sub-populations containing 100% of either Pil+ or Pil2
bacteria were never obtained. Consequently, the analysis of pilus
expression (both by microarray and western blot) was performed
by comparing two sub-populations, H and L, enriched in Pil+ and
Pil2 bacteria, respectively. Microarray expression profiling was
only able to detect a significant change in expression for the PI-1
components, including the rlrA positive regulator, while changes in
the expression of genes outside of the PI-1 in the five strains tested
(H vs. L sub-populations) remained undetected. Moreover, as
clearly demonstrated in this work, RlrA (unlike RrgB and SrtC-2)
expression was sufficient to induce the polymerization of a
functional pilus on Pil- pneumococci, resulting in the switch of
pilus biosynthesis from an ‘‘off’’ to an ‘‘on’’ state. The latter
observation is in agreement with previous reports identifying RlrA
as the positive regulator of PI-1 genes transcription, able to
activate its own transcription and to establish a positive feedback
loop [22]. Additionally, this phenomenon is supported by the
difference in the rlrA transcript observed in the H vs L sub-
populations. Indeed, the rlrA transcriptional change is in the range
of that observed for the three PI-1 sortases (and much lower than
that observed for the structural subunits), thus in agreement with
the idea that for regulatory proteins and enzymes (exerting
catalytic activity), small transcriptional changes could be sufficient
to induce an appreciable phenotypic difference. Taken together
these data suggest two possible scenarios: i) pilus expression is
modulated by the interplay of numerous regulators, but transcrip-
tional changes outside PI-1 remained undetected by our assay as
would be expected since very slight changes in a regulatory
transcript could be responsible for important phenotypic changes,
especially when elaborated like in this case indirectly through
another regulator; ii) pilus expression is not dependent on
regulators located outside PI-1, but direct changes are in response
to unknown external stimuli or noise increasing the transcription
of rlrA and thus switching ‘‘on’’ the pilus biosynthesis. Additional
data obtained analyzing pilus expression at the single cell level in
knock-out mutants of the known PI-1 repressors, seem to exclude
the possibility of their direct involvement in pilus regulation (data
not shown), and therefore favor the second hypothesis.
Although the molecular mechanisms triggering such regulation
events are still not clear, the data presented in this work suggest
that S. pneumoniae pilus expression could be an example of
bistability, as it was recently suggested for Streptococcus pyogenes
FCT3 encoded pili [56]. In fact, this term is usually referred to
phenotypic variation examples where: 1) two stable expression
states coexist within a population; 2) noise or different factors
operate across the entire population driving cells to switch into the
alternative expression state and determine the overall switching
probability; 3) the regulation occurs through the presence of
feedback loops, either positive or double negative [57–59].
Moreover, bistability is epigenetic in nature (not caused by a
change in the DNA sequence). In this regard, our data exclude the
possibility of phase variation events within PI-1, but genetic
modifications present elsewhere in the genome (still unexplored)
could indirectly influence pilus expression.
The molecular basis and the biological benefit of this bistability
phenomenon are currently unknown. Presumably, such switching
mechanisms have evolved as a way for bacteria to be
phenotypically pre-adapted to survive present or pending adverse
conditions. Most likely, this heterogeneity helps the bacterium to
utilize different niches within an ecosystem, and even has the
potential to increase the overall fitness of the species, and prepare
Pneumococcal Pilus-1 Biphasic Expression
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response to stress or different environmental conditions.
In conclusion, this study has shown that pilus expression follows
a biphasic pattern, and is an on-off regulated mechanism
occurring at the transcriptional level and involving all the PI-1
components, included the PI-1 positive regulator RlrA (there could
be multiple promoter regions within PI-1 responding to RlrA
positive regulation). Further studies are necessary to better clarify
the molecular mechanisms responsible for the biphasic pilus
phenotype. This finding suggests that new experimental approach-
es should be devised to assess the contribution of pilus-1 to
virulence. In addition, the discovery of this byphasic phenotype
points toward the need to evaluate the expression of the
pneumococcal pilus during infection and to understand if in vivo
conditions will modulate the pilus expression ratio, or if, for still
unknown reasons, the coexistence of the two heterogeneous sub-
populations is necessary to exploit the pilus virulence potential.
Materials and Methods
Bacterial strains and growth conditions
S. pneumoniae strains were routinely grown over night (ON) at
37uCi n5 %C O 2 on Tryptic Soy Agar plates (TSA) (Becton
Dickinson) supplemented with 10 mg/l colistine, 5 mg/l oxolinic
acid, and 5% defibrinated sheep blood. Liquid cultures were
carried out statically at 37uC under 5% CO2 humidified
atmosphere until A600 = 0.25 in Todd Hewitt Broth supplement-
ed 0.5% (w/w) yeast extract (THYE) unless otherwise specified
(Becton Dickinson). To evaluate pilus-1 expression changes in
response to different growth conditions the following experimental
settings were used: rich media (THYE, Tryptic Soy Broth, Brain
Hearth Infusion broth) or a chemically defined minimal medium
[60] supplemented either with MnSO4 (1 mM), FeCl3 ($50 mM)
or Fetal Bovine Serum (20%); bacteria were also grown until
different growth phases (A600 ranging from 0.01 to 1.2), at different
pH values (5.5, 6.4, 8.4) or in the presence of different O2
concentrations.
Strain collection
A worldwide collection of 1366 strains of S. pneumoniae (Figure
S4) including both carriage, AOM (acute otitis media) and invasive
clinical isolates from different geographical origins, were charac-
terized for serotype (with conventional methods) and sequence
type (ST), for the presence of the PI-1 and for PI-1 clade. Multi
Locus Sequence Typing (MLST), Clonal Complex (CC) assign-
ment by E-BURST analysis, and PI-1 detection were performed as
previously described [28]. The evaluation of pilus expression was
performed on a sub-panel of strains randomly selected from
among those that resulted PI-1 positive within this collection.
Genomic DNA extraction and PI-1 sequencing
Genomic DNA extractions were performed from 50 ml of
bacterial liquid culture by using the Wizard Genomic DNA
purification kit following the manufacturer’s instructions (Pro-
mega). To obtain PI-1 sequences, oligonucleotides matching on
homologous regions inside the islands were designed and used to
amplify and sequence the PCR products (Table S1). Sequences
were obtained by use of an ABI 3730xl DNA Analyzer and
assembled with Vector NTI 10.
Animal immunizations
Animal treatments were done in compliance with the current
law, approved by the internal Animal Ethics Committee (AEC
numbers 200601, 200602, 200607 and 200911) and authorized by
the Italian Ministry of Health. To generate sera against the specific
proteins, purified recombinant proteins were used to immunize
CD1 mice (20 mg, three doses administered intra-peritoneally two
weeks apart) or New Zealand rabbits of 2.5 kg body weight
(100 mg, three doses subcutaneous immunization two weeks apart)
(Charles River Laboratory). Two weeks after the third immuni-
zation the animals were bled to obtain the sera. A rabbit
polysaccharide multivalent antiserum (OMNIserum) was pur-
chased from Staten Serum institute (Copenhagen).
Flow Cytometry on whole bacteria
Bacteria recovered from liquid cultures were stained with mouse
antisera raised against pilus-1 components or surface exposed
proteins (final dilution 1:300). After labelling with a secondary
FITC conjugated antibody (Jackson Laboratories, dilution 1:100),
bacteria were fixed with 2% paraformaldehyde. Bacterial staining
was analyzed by using a FACS-Calibur cytometer (Becton
Dickinson). Sera from mice immunized with PBS (Phosphate
Buffered saline) plus adjuvant were used as a negative control. To
test the pilus-1 expression in the presence of antibodies directed
against RrgB, the bacteria were grown from an A600 of 0.01 to 1.2
in THYE supplemented with anti-RrgB rabbit sera at different
dilutions (1:20, 1:50, 1:100). The growth was also carried out with
rabbit anti-BgaA and with sera derived from animals immunized
with adjuvant only (1:20, 1:50, 1:100), used as negative controls.
When the desired A600 was reached, bacteria were processed for




with PBS pH 7.4, fixed with 2% (w/v) paraformaldehyde in PBS
and then attached to polylysine-coated cover slips. After washing
five times with PBS the slides were blocked for 15 min with PBS 3%
BSA (w/v) (Bovine serum albumin) supplemented with 10% normal
goat serum (Sigma). Primary and secondary antibodies conjugated
with fluorochromes (Invitrogen) were diluted in PBS containing 1%
BSA and incubated with the bacterial cells for 30 min at room
temperature. Between incubation steps the bacteria were washed
thoroughly with PBS. To reduce bleaching of the fluorochromes,
the slides were mounted in Pro Long Gold antifade reagent with
DAPI (Invitrogen). Images were obtained using a Carl Zeiss LSM
7MP Laser Scanning Microscope.
Depletion of RrgB positive bacteria
TIGR4 low pilus expressing bacteria were incubated with rabbit
anti-RrgB antibodies (1:400 dilution) and then with goat anti-
rabbit IgG biotin conjugated (Abcam, 1:1000 dilution) antibodies.
Labelled bacteria were then incubated with Sepharose magnetic
beads coated with streptavidin (Invitrogen) for 1 h at 4uC. Finally,
RrgB positive bacteria attached to the Sepharose beads were
removed by placing the tubes in a magnetic separation rack and
recovering the bacterial suspension (containing RrgB negative
bacteria).
SDS-PAGE and Western Blot analysis
SDS-PAGE analysis was performed on whole bacterial lysates
using Nu-PAGE
TM 4-12 Bis-Tris or 3-8% Tris-acetate gradient
gels (Invitrogen) according to the manufacturer’s instructions. Hi-
Mark
TM pre-stained HMW protein standard (Invitrogen) served as
a protein standard. Gels were processed for Western Blot analysis
by using standard protocols. Mouse and rabbit antibodies raised
against recombinant His-Tag-proteins were used at 1:3000 and
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anti-rabbit IgG alkaline phosphatase conjugated antibodies
(Promega) were used at 1:5000 and the signal developed by using
Western Blue Stabilized Substrate for Alkaline Phosphatase
(Promega).
Colony immuno-blot
Bacteria were diluted on blood-agar plates to obtain isolated
colonies. Before plating the bacteria underwent three sonication
cycles (30 seconds, power 50% with a SONICS vibra-cell
sonicator), to ensure that the colonies were derived from single
bacteria. The effectiveness of sonication was checked by inspection
of the bacteria under the microscope before and after the
treatment. Following ON growth, nitrocellulose membrane discs
(Millipore) were gently placed on the plates, removed after 5 min,
heat-treated with microwave irradiation (300 W for 2 min) and
then processed for Western Blot analysis as described above.
RNA extraction
RNAprotect bacterial reagent (Qiagen) was added to 2 ml
liquid bacterial culture (2:1) and the mixture vortexed for a few
seconds. After 5 min at room temperature the bacterial pellet was
recovered by centrifugation (5000 g, 10 min), resuspended in 1 ml
prewarmed (100uC) SDS solution (SDS 2%, 16 mM EDTA
pH 8.00) and incubated at 100uC for 2 min, under vigorous
shaking. Prewarmed (65uC) acid phenol (1 ml) was then added to
the samples, that were incubated for 5 min at 65uC under shaking,
and then extracted twice with 1 ml Phenol/Chloroform/Isoamyl
alcohol (25:24:1) and once with 1 ml Chloroform/Isoamyl alcohol
(24:1). The aqueous phase containing the RNA was recovered by
sample centrifugation and the RNA precipitation was carried out
by adding 2.5 volumes of ethanol and 1/10 vol of Na Acetate 3 M
(pH 4.5). After 2 h of incubation at 220uC and centrifugation
(16000 g, 20 min), the RNA pellet was recovered and purified by
using RNeasy Mini Kit (Qiagen) according to manufacturer’s
instructions. Before the final elution, all RNA samples were
subjected two times to a DNase I treatment (Qiagen). Total RNA
integrity check was performed on agarose gel.
Microarray design
Gene expression analysis was performed by using a custom
made microarray based on dsDNA fragments (200–500 bp), PCR-
amplified on TIGR4 genomic DNA. In the design were also
included amplicons matching on specific genes selected from
additional five S. pneumoniae strains (R6, G54, 70585, P1031 and
Taiwan-19F 14). Genes were considered non-specific if they had a
corresponding homologous gene in TIGR4 with an identity
greater than 80% on at least 80% of the gene length. An
additional stringency criterion was applied for the gene selection
from 70585, P1031 and Taiwan-19F 14 genomes: genes matching
with the amplicons already designed on TIGR4, R6 and G54,
having an identity of 87% on at least 70 bp of length, and having
lengths shorter than 180 bp, were removed. Furthermore,
amplicons corresponding to the genes present in two D39 strain
plasmids (pDP1 and pSMB1) and in the serotype 2 capsule
biosynthesis locus (D39), as well as those corresponding to the PI-1
genes specific for Clade II (Finland 6B-12) and Clade III (Taiwan
23F-15) were added.
Amplification primers were designed by Primer3 software (v.
1.0b) [61]. Usually, one pair of primers was designed for each
gene; in the case of 337 genes in TIGR4 and 19 genes in R6,
multiple primer pairs (ranging from 2 to 7) were designed on the
same gene. The resulting coverage in TIGR4 is of 2121/2236
(94.6%) predicted open reading frames (25 fragments cover 2 or
more genes that are contiguous, extremely similar or paralogous).
For the other S. pneumoniae strains, the primer pairs designed on
specific genes cover the following number of open reading frames:
144 (R6), 22 (G54), 126 (70585), 120 (P1031), 114 (19F Taiwan
14), 5 (D39 pDP1 and pSMB1) 15 (D39 capsule), 6 (PI-1 Clade II
and Clade III). The possible resulting coverage was rechecked by
sequence homology between the amplicons and the predicted
genes in the additional S. pneumoniae strains, requiring at least
70 bp of alignment with an identity of at least 87%. The resulting
coverage, based on NCBI annotations is: R6 1879/2043 (92%),
G54 1911/2047 (93.4%), 70585 1890/2323 (81.4%), P1031
1955/2254 (87.8%), 19F Taiwan 14 1917/2205 (86.9%).
PCR amplifications were performed on the genomic DNAs
(prepared as described above), purified using QIAquick-96 PCR
purification plates (Qiagen), eluted in ddH2O before to be checked
by gel electrophoresis on a 96-well format and finally diluted with
DMSO (dimethyl sulfoxide) 50% (vol/vol). All the PCR-amplified
fragments were spotted in quadruplicate by using a Microgrid II
spotter (Arrayit Corporation) on Type-VII* aluminium-coated
mirrored slides (ArrayJet). Two hundred and one spots were
spotted with a higher number of replicas (varying from 8 to 32).
Negative controls, such as PCR-processed empty buffer (spots
indicated as ‘H2O’) and spotter-processed empty buffer (spots
indicated as ‘empty’), were also included.
The chip layout was submitted to the EBI ArrayExpress and is
available with the identifier A-MEXP-2001.
Probe labeling and microarray hybridization
For RNA labeling, 1 mg total RNA, prepared as described above,
was reverse transcribed for two hours at 42uC using Super Script II
Reverse Trascriptase (Invitrogen), random nonamer oligonucleo-
tides (GE Healthcare) and the fluorochromes Cyanine3-dCTP or
Cyanine5-dCTP (GE Healthcare). Following the reverse transcrip-
tion reaction, labeled cDNA was treated with RNAse (RNAse One,
Promega and RNAse H, Invitrogen) at 37uC for 30 min and than
purified by using the Qiaquick PCR purification kit (Qiagen),
according to the manufacturer’s instructions. The incorporation
efficiency of the Cy3 or Cy5 dCTP was measured by NanoDrop
analysis. Following heat denaturation (2 min at 95uC), equal
amounts of Cy5- and Cy3-labeled cDNAs were used to hybridize
microarray slides (over night incubation at 42uC) in microarray
hybridization buffer (GE Healthcare) and 50% formamide. Slides
were then washed once for 5 min in SSC solution (150 mM NaCl
and 15 mM Sodium Citrate) 0.2% SDS, and twice for 10 min in
0.1x SSC 0.2% SDS. Finally, the slides were dipped 5 times in 0.1X
SSC, 2 times in water and then dried with nitrogen. Images were
acquiredwithPowerScanner(Tecan) at5 and 10 mm resolution and
analyzed with Genepix 6.1 (Axon laboratories).
Microarray data analysis
Data normalization was performed with the application BASE2
[62] by using a lowess transformation, as implemented in the R
software environment, by the loess function after an intra-slide
median centering and a low intensity spot correction (if the
average spot intensity was less than one standard deviation of the
background signal the intensity spot was corrected to the same
value of one standard deviation of the background signal).
Differential gene expression was assessed by grouping all log2
ratio values corresponding to each gene within experimental
replicas and spot replicas, and comparing them against the zero
value by Student’s t-test statistics (one tail). Genes having a t-test p-
value ,0.05 were usually accepted as differentially expressed.
Type-I error rate was estimated by q-value method [63]. A log2
ratio threshold filtering was also applied, and genes with a log2
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significantly changed. The threshold was inferred from log2 ratio
distribution widths (standard deviation between 0.25 and 0.44 and
an average of 0.31) observed in each sample.
Hierarchical clustering was applied as implemented by MeV
software (v. 4.2) [64] using the Euclidean metrics and the average
agglomeration method.
Microarray data were submitted to the EBI ArrayExpress and
are available with the identifier E-TABM-1154.
Gene expression changes were validated by quantitative real-
time PCR (qRT_PCR) analysis. The primers used for qRT-PCR
analysis are reported in Table S2. The qRT-PCR reaction was
performed in a Light Cycler 480 II (Roche) by using the Light
Cycler RNA amplification kit SYBR green I (Roche) according to
the manufacturer’s instructions. For each gene, duplicate reactions
were performed on the RNA samples isolated from separate
assays. Analyses were performed with Light CyclerH 480 SW 1.5
(Roche). The relative quantitation method (threshold cycle DDCT)
was used to evaluate the quantitative variation in gene expression
between the high and low pilus expressing subpopulations for the 5
different strains tested, relative to each gene examined. The S16
and GAPDH (glyceraldehyde 3-phosphate dehydrogenase) ampli-
cons were used as the endogenous control for the normalization of
the data.
Expression of RrgB or RlrA in TIGR4 low pilus expressing
bacteria
The rlrA, the rrgB and the srtC-2 genes were amplified from
chromosomal DNA of TIGR4 strain by PCR by using the primers
listed in Table S3. The PCR products were cloned into the
complementation plasmid pMU1328 between BamHI and SalI
restriction sites [51]. Expression of RlrA, RrgB and SrtC-2 was
under the control of the erythromycin constitutive promoter (Pc),
which was amplified with the primers listed in Table S3 and
cloned immediately upstream rlrA, rrgB or srtC-2 (EcoRI, BamHI).
All plasmids were confirmed by sequencing, and then transformed
into TIGR4 low pilus expressing bacteria by conventional
methods. Transformant selection was performed by supplement-
ing media with erythromycin (1 mg/ml). Bacteria containing the
pMU1328 Pc_rlrA, Pc_rrgB or Pc_srtC-2 plasmids were analyzed by
PCR. Expression of pili on the bacterial surface was detected by
Western blot, FACS and immune-fluorescence analysis of whole
cell lysates.
Supporting Information
Figure S1 Pilus expression ratio is constant at different
growth phases. Bacteria expressing pilus-1 of clade I (A,
TIGR4), clade II (B, 6B Finland 12) or clade III (C, 35B SME15)
were grown in THYE at different A600 (0.02, 0.1, 0.25, 0.5 and 1)
and labeled with clade specific anti-RrgB antibodies (1:400
dilution), and FITC anti-mouse IgG secondary antibodies (1:100
dilution). Pilus-1 expression was then analyzed by flow cytometry
(FACS-Calibur).
(TIF)
Figure S2 Microarray expression profile analysis of the
high versus the low pilus expressing sub-populations. A)
Hierarchical clustering representation of complete microarray
data. Blue bars indicate genes significantly differentially regulated
in at least one strain. B) Gene expression profiling of the genes
differentially regulated in A. Numbers represent the log2 ratios.
*P ,0.05. C) Pilus-1 expression repressors reported in the
literature are not differentially expressed. Gene expression
profiling of high versus low pilus expressing sub-populations for
strains TIGR4 (Clade I), 19F Taiwan 14 (Clade I), OREP4 (Clade
I), 6B Finland 14 (Clade II) and 35B SME 15 (Clade III), by
spotted DNA microarray analysis. The data are measures of
relative gene expression in in vitro growth liquid cultures. Red and
green represent high and low experimental high/low pilus
expression ratios for the 5 strains tested, respectively (see scale
bar). The columns represent arrays of different strains (two
hybridizations were performed with independently prepared
samples), and the rows represent the genes. Red and green
correspond to high and low experimental high/low pilus
expression ratios for the 5 strains tested, respectively (see log2
ratio scale bar).
(TIF)
Figure S3 SrtC-2 is expressed and functional in bacteria
transformed with pMU1328-Pc-srtC-2. WB analysis per-
formed using polyclonal mouse antisera against RrgB and SrtC-2
on whole bacterial lysates shows that: SrtC-2 is expressed in the
TIGR4L sub-population when TIGR4L is transformed with
pMU1328 Pc_srtC-2; SrtC-2 expression does not influence RrgB
expression; and the over-expression of SrtC-2 in TIGR4DsrtC-1-3
expressing RrgB in a monomeric form, restores RrgB polymer-
ization. Samples were loaded as follows: TIGR4 wt (lane 1),
TIGR4DsrtC-1-3 (lane 2) and TIGR4DsrtC-1-3 transformed with
pMU1328-Pc-srtC-2 (lane 3), TIGR4L transformed with pMU1328
empty vector (lane 4), pMU1328-Pc-srtC-2 (lane 5), pMU1328-Pc-
rlrA (lane 6), or pMU1328-Pc-rrgB (lane 7).
(TIF)
Figure S4 Composition of the Novartis S. pneumoniae
global collection. Geographical origin, number of strains and
disease outcome are indicated (ID: invasive disease, C: carriage,
AOM: acute otitis media).
(TIF)
Table S1 Oligonucleotides used to amplify and se-
quence PI-1 islets of clade I, II and III.
(DOCX)
Table S2 Oligonucleotides used in qRT-PCR to validate
microarray data.
(DOCX)
Table S3 Oligonucleotides used to constructs pMU1328
plasmids expressing RrgB or RlrA. Underlined sequences
correspond to the restriction sites used for cloning.
(DOCX)
Text S1 Generation of a TIGR4 srtC1-3 deletion mu-
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